Lubricin function in articulating joints

润滑素在关节中的作用

基本信息

  • 批准号:
    7915518
  • 负责人:
  • 金额:
    $ 48.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-01 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The integrity of the cartilage surface and its surrounding synovium affects the homeostasis and long-term function of an articulating joint. This is a competitive renewal application to continue our studies of the secreted protein lubricin (encoded by the gene PRG4), which is expressed by superficial zone chondrocytes and type B synoviocytes. We and other investigators have shown that lubricin is critically important in the protection and maintenance of articulating joints. We have demonstrated that lubricin prevents mechanical wear of articular cartilage. Humans and mice that genetically lack lubricin develop precocious cartilage failure and synovial hyperplasia. We have observed acquired alterations of lubricin in patients with common joint diseases, including osteoarthritis, rheumatoid arthritis, and traumatic joint injury. These acquired alterations of lubricin can include changes in protein abundance, the expression of different protein splice-forms, and specific post-translational processing events, such as glycosylation and protein cleavage, which appear to be important to the protein's biological and mechanical activities. We have three overall research goals. First, we want to understand precisely how the different lubricin splice-forms and post-translational modifications contribute to the protein's diverse cell biologic, structural, and biophysical properties. We will accomplish this by studying protein and tissue recovered from wild-type animals, lubricin-mutant animals, and transgenic mice that express specific lubricin splice-forms or lubricin proteins that have been mutated to prevent normal post-translational processing. In aim two we will develop a reliable and reproducible methodology for inducing and measuring wear in whole joints. This will enable us to understand how lubricin prevents wear in vivo. It is important to appreciate that not all good lubricants prevent wear. Therefore, we want to precisely define how lubricin prevents wear and which of its post-translational modifications are important to this activity. Third, we want to correlate acquired alterations of lubricin with common diseases of joints and determine whether these lubricin alterations are causes or consequences. We will do this by analyzing synovial fluid and serum from cohorts of patients affected by common joint diseases and from animal models of acquired joint disease, such as traumatic joint injury and inflammatory arthritis. PUBLIC HEALTH RELEVANCE. This research aims to understand how the secreted protein lubricin protects mammalian joints. Genetic absence of lubricin cause precocious joint failure. Our preliminary data suggest that acquired alterations of lubricin contribute to the progression of joint disease in patients with more common diseases affecting joints, such as osteoarthritis, rheumatoid arthritis, and traumatic joint injury. We will study mice that express different forms of lubricin and also study biologic samples from patients with normal and damaged joints to begin correlating lubricin variation with human joint health.
描述(由申请人提供):软骨表面及其周围滑膜的完整性影响关节的稳态和长期功能。这是一个有竞争力的更新申请,以继续我们对分泌蛋白润滑素(由基因PRG 4编码)的研究,该蛋白由浅区软骨细胞和B型滑膜细胞表达。我们和其他研究人员已经表明,润滑素是至关重要的保护和维护关节。我们已经证明润滑素可以防止关节软骨的机械磨损。遗传上缺乏润滑素的人类和小鼠会发生早熟的软骨衰竭和滑膜增生。我们已经观察到获得性改变的润滑素在常见的关节疾病,包括骨关节炎,类风湿性关节炎,创伤性关节损伤的患者。润滑素的这些获得性改变可以包括蛋白质丰度的变化、不同蛋白质剪接形式的表达以及特定的翻译后加工事件,如糖基化和蛋白质切割,这似乎对蛋白质的生物学和机械活性很重要。我们有三个总体研究目标。首先,我们希望精确地了解不同的润滑素剪接形式和翻译后修饰如何有助于蛋白质的不同细胞生物学,结构和生物物理特性。我们将通过研究从野生型动物、润滑素突变动物和转基因小鼠中回收的蛋白质和组织来实现这一目标,这些动物表达特定的润滑素剪接形式或润滑素蛋白质,这些蛋白质已被突变以阻止正常的翻译后加工。在目标二中,我们将开发一种可靠的和可重复的方法来诱导和测量整个关节的磨损。这将使我们能够了解润滑素如何防止体内磨损。重要的是要认识到,并非所有好的润滑剂都能防止磨损。因此,我们希望精确地定义润滑素如何防止磨损,以及它的哪些翻译后修饰对这种活性很重要。第三,我们希望将获得性润滑素改变与常见关节疾病联系起来,并确定这些润滑素改变是原因还是后果。我们将通过分析受常见关节疾病影响的患者队列和获得性关节疾病(如创伤性关节损伤和炎性关节炎)动物模型的滑液和血清来实现这一点。公共卫生相关性。本研究旨在了解分泌的蛋白质润滑素如何保护哺乳动物关节。遗传性缺乏润滑素会导致过早的关节衰竭。我们的初步数据表明,润滑素的获得性改变有助于患有影响关节的更常见疾病(例如骨关节炎、类风湿性关节炎和创伤性关节损伤)的患者的关节疾病进展。我们将研究表达不同形式润滑素的小鼠,并研究来自正常和受损关节患者的生物样本,以开始将润滑素变化与人类关节健康联系起来。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GREGORY D. JAY其他文献

GREGORY D. JAY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GREGORY D. JAY', 18)}}的其他基金

RI COBRE: ASSESSMENT OF CHONDROPROTECTION IN ACL INJURIES
RI COBRE:ACL 损伤中软骨保护的评估
  • 批准号:
    8168038
  • 财政年份:
    2010
  • 资助金额:
    $ 48.79万
  • 项目类别:
Tribosupplementation of Injured Joints
受伤关节的摩擦补充
  • 批准号:
    7670043
  • 财政年份:
    2009
  • 资助金额:
    $ 48.79万
  • 项目类别:
RI COBRE: ASSESSMENT OF CHONDROPROTECTION IN ACL INJURIES
RI COBRE:ACL 损伤中软骨保护的评估
  • 批准号:
    7959906
  • 财政年份:
    2009
  • 资助金额:
    $ 48.79万
  • 项目类别:
Tribosupplementation of Injured Joints
受伤关节的摩擦补充
  • 批准号:
    8455361
  • 财政年份:
    2009
  • 资助金额:
    $ 48.79万
  • 项目类别:
RI COBRE: ASSESSMENT OF CHONDROPROTECTION IN ACL INJURIES
RI COBRE:ACL 损伤中软骨保护的评估
  • 批准号:
    7721009
  • 财政年份:
    2008
  • 资助金额:
    $ 48.79万
  • 项目类别:
Restitution of Lubrication in ACL Deficient Joints Preventing Wear
ACL 缺陷关节的润滑恢复防止磨损
  • 批准号:
    7615686
  • 财政年份:
    2008
  • 资助金额:
    $ 48.79万
  • 项目类别:
Restitution of Lubrication in ACL Deficient Joints Preventing Wear
ACL 缺陷关节的润滑恢复防止磨损
  • 批准号:
    7434907
  • 财政年份:
    2008
  • 资助金额:
    $ 48.79万
  • 项目类别:
RI COBRE: ASSESSMENT OF CHONDROPROTECTION IN ACL INJURIES
RI COBRE:ACL 损伤中软骨保护的评估
  • 批准号:
    7610824
  • 财政年份:
    2007
  • 资助金额:
    $ 48.79万
  • 项目类别:
Pulsus Paradoxus Monitor
奇脉监测仪
  • 批准号:
    6788511
  • 财政年份:
    2004
  • 资助金额:
    $ 48.79万
  • 项目类别:
Pulsus Paradoxus Monitor
奇脉监测仪
  • 批准号:
    6949921
  • 财政年份:
    2004
  • 资助金额:
    $ 48.79万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.79万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 48.79万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.79万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.79万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.79万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.79万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.79万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 48.79万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 48.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 48.79万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了